0001104659-22-130251.txt : 20221227
0001104659-22-130251.hdr.sgml : 20221227
20221227185002
ACCESSION NUMBER: 0001104659-22-130251
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211121
FILED AS OF DATE: 20221227
DATE AS OF CHANGE: 20221227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Poll Claire
CENTRAL INDEX KEY: 0001836820
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 221491396
MAIL ADDRESS:
STREET 1: C/O VERONA PHARMA PLC
STREET 2: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4
1
tm2233427-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-11-21
0
0001657312
Verona Pharma plc
VRNA
0001836820
Poll Claire
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
0
1
0
0
General Counsel
Ordinary Shares
2021-11-21
4
G
0
90104
0
D
2472951
D
Ordinary Shares
2021-11-21
4
G
0
90104
0
A
573944
I
By Trust
Ordinary Shares
2022-02-22
5
G
0
E
90104
0
D
2382847
D
Ordinary Shares
2022-02-22
5
G
0
E
90104
0
A
664048
I
By Trust
Ordinary Shares
2022-05-22
5
G
0
E
90104
0
D
2292743
D
Ordinary Shares
2022-05-22
5
G
0
E
90104
0
A
754152
I
By Trust
Ordinary Shares
2022-08-21
5
G
0
E
90104
0
D
2202639
D
Ordinary Shares
2022-08-21
5
G
0
E
90104
0
A
844256
I
By Trust
Ordinary Shares
2022-11-22
5
G
0
E
170000
0
D
2032639
D
Ordinary Shares
2022-11-22
5
G
0
E
170000
0
A
1014256
I
By Trust
Ordinary Shares
2022-12-22
4
S
0
240000
2.6918
D
774256
I
By Trust
Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer.
Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.
Consists of (i) 1,990,000 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which may be represented by 248,750 ADSs); (ii) 42,632 Ordinary Shares underlying 5,329 ADSs; and (iii) 7 Ordinary Shares.
The price reported represents the weighted average sale price of the ADSs divided by eight (8). These shares were sold in multiple transactions at prices ranging from $2.675 to $2.7138, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Claire Poll
2022-12-27